vs
Side-by-side financial comparison of EASTERN CO (EML) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $55.3M, roughly 1.0× EASTERN CO). EASTERN CO runs the higher net margin — 1.0% vs -83.0%, a 84.0% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs -22.4%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs -0.6%).
EASTERN COEMLEarnings & Financial Report
China Eastern Airlines is a major airline in China, headquartered in Changning, Shanghai. It is one of the three major airlines in the country, along with Air China and China Southern Airlines.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
EML vs RYTM — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $55.3M | $57.3M |
| Net Profit | $578.9K | $-47.5M |
| Gross Margin | 22.3% | 91.6% |
| Operating Margin | 3.1% | -82.2% |
| Net Margin | 1.0% | -83.0% |
| Revenue YoY | -22.4% | 36.9% |
| Net Profit YoY | 103.8% | -9.6% |
| EPS (diluted) | $0.10 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $57.3M | ||
| Q3 25 | $55.3M | $51.3M | ||
| Q2 25 | $70.2M | $48.5M | ||
| Q1 25 | $63.3M | $32.7M | ||
| Q4 24 | $64.3M | $41.8M | ||
| Q3 24 | $71.3M | $33.3M | ||
| Q2 24 | $72.6M | $29.1M | ||
| Q1 24 | $64.6M | $26.0M |
| Q4 25 | — | $-47.5M | ||
| Q3 25 | $578.9K | $-52.9M | ||
| Q2 25 | $3.4M | $-46.6M | ||
| Q1 25 | $1.9M | $-49.5M | ||
| Q4 24 | $1.3M | $-43.3M | ||
| Q3 24 | $-15.3M | $-43.6M | ||
| Q2 24 | $3.5M | $-32.3M | ||
| Q1 24 | $1.9M | $-141.4M |
| Q4 25 | — | 91.6% | ||
| Q3 25 | 22.3% | 89.3% | ||
| Q2 25 | 23.3% | 88.6% | ||
| Q1 25 | 22.4% | 88.8% | ||
| Q4 24 | 23.6% | 90.9% | ||
| Q3 24 | 25.5% | 88.5% | ||
| Q2 24 | 25.4% | 89.9% | ||
| Q1 24 | 23.9% | 89.2% |
| Q4 25 | — | -82.2% | ||
| Q3 25 | 3.1% | -102.6% | ||
| Q2 25 | 4.5% | -93.4% | ||
| Q1 25 | 5.1% | -143.7% | ||
| Q4 24 | 6.1% | -98.6% | ||
| Q3 24 | 9.5% | -132.0% | ||
| Q2 24 | 8.3% | -139.2% | ||
| Q1 24 | 5.3% | -538.7% |
| Q4 25 | — | -83.0% | ||
| Q3 25 | 1.0% | -103.1% | ||
| Q2 25 | 4.9% | -96.1% | ||
| Q1 25 | 3.1% | -151.4% | ||
| Q4 24 | 2.0% | -103.6% | ||
| Q3 24 | -21.5% | -131.2% | ||
| Q2 24 | 4.8% | -110.9% | ||
| Q1 24 | 3.0% | -544.4% |
| Q4 25 | — | $-0.73 | ||
| Q3 25 | $0.10 | $-0.82 | ||
| Q2 25 | $0.56 | $-0.75 | ||
| Q1 25 | $0.32 | $-0.81 | ||
| Q4 24 | $0.22 | $-0.71 | ||
| Q3 24 | $-2.46 | $-0.73 | ||
| Q2 24 | $0.56 | $-0.55 | ||
| Q1 24 | $0.31 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $9.2M | $388.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $124.3M | $139.1M |
| Total Assets | $220.0M | $480.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $388.9M | ||
| Q3 25 | $9.2M | $416.1M | ||
| Q2 25 | $9.1M | $291.0M | ||
| Q1 25 | $10.2M | $314.5M | ||
| Q4 24 | $16.1M | $320.6M | ||
| Q3 24 | $9.7M | $298.4M | ||
| Q2 24 | $2.0M | $319.1M | ||
| Q1 24 | $2.1M | $201.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $42.2M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $139.1M | ||
| Q3 25 | $124.3M | $148.8M | ||
| Q2 25 | $124.4M | $-11.9M | ||
| Q1 25 | $121.0M | $18.9M | ||
| Q4 24 | $120.7M | $21.7M | ||
| Q3 24 | $119.2M | $11.2M | ||
| Q2 24 | $136.5M | $39.3M | ||
| Q1 24 | $134.5M | $61.6M |
| Q4 25 | — | $480.2M | ||
| Q3 25 | $220.0M | $506.9M | ||
| Q2 25 | $229.4M | $372.7M | ||
| Q1 25 | $232.3M | $386.7M | ||
| Q4 24 | $235.3M | $392.3M | ||
| Q3 24 | $244.2M | $363.6M | ||
| Q2 24 | $255.9M | $381.8M | ||
| Q1 24 | $253.9M | $258.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.35× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.1M | $-25.4M |
| Free Cash FlowOCF − Capex | $3.1M | — |
| FCF MarginFCF / Revenue | 5.5% | — |
| Capex IntensityCapex / Revenue | 0.1% | — |
| Cash ConversionOCF / Net Profit | 5.38× | — |
| TTM Free Cash FlowTrailing 4 quarters | $12.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-25.4M | ||
| Q3 25 | $3.1M | $-26.6M | ||
| Q2 25 | $3.8M | $-23.3M | ||
| Q1 25 | $-1.8M | $-40.4M | ||
| Q4 24 | $11.0M | $-18.8M | ||
| Q3 24 | $-2.9M | $-25.2M | ||
| Q2 24 | $8.4M | $-29.1M | ||
| Q1 24 | $2.8M | $-40.7M |
| Q4 25 | — | — | ||
| Q3 25 | $3.1M | — | ||
| Q2 25 | $3.0M | — | ||
| Q1 25 | $-2.7M | — | ||
| Q4 24 | $9.0M | — | ||
| Q3 24 | $-7.7M | — | ||
| Q2 24 | $7.3M | — | ||
| Q1 24 | $1.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | 5.5% | — | ||
| Q2 25 | 4.3% | — | ||
| Q1 25 | -4.3% | — | ||
| Q4 24 | 13.9% | — | ||
| Q3 24 | -10.8% | — | ||
| Q2 24 | 10.1% | — | ||
| Q1 24 | 1.7% | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 3.2% | — | ||
| Q3 24 | 6.7% | — | ||
| Q2 24 | 1.5% | — | ||
| Q1 24 | 2.6% | — |
| Q4 25 | — | — | ||
| Q3 25 | 5.38× | — | ||
| Q2 25 | 1.09× | — | ||
| Q1 25 | -0.95× | — | ||
| Q4 24 | 8.41× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.40× | — | ||
| Q1 24 | 1.43× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
